The CD74 inhibitor DRhQ improves short-term memory and mitochondrial function in 5xFAD mouse model of Aβ accumulation - Noah Gladen-Kolarsky; Cody J. Neff; Wyatt Hack; Mikah S. Brandes; Jack Wiedrick; Roberto Meza-Romero; Denesa R. Lockwood; Joseph F. Quinn; Halina Offner; Arthur A. Vandenbark; Nora E. Gray (Metabolic Brain Disease, 2025)

Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in mice - Tia C. L. Kohs; Meghan E. Fallon; Ethan C. Oseas; Laura D. Healy; Erik I. Tucker; David Gailani; Owen J. T. McCarty; Arthur A. Vandenbark; Halina Offner; Norah G. Verbout (Metabolic Brain Disease, 2023)

PD-L1 is required for estrogen-induced protection against severe EAE in IL-10 deficient mice1 - Halina Offner; Denesa Lockwood; Roberto Meza-Romero; Arthur A. Vandenbark (Metabolic Brain Disease, 2023)

A Novel Partial MHC Class II Construct, DRmQ, Inhibits Central and Peripheral Inflammatory Responses to Promote Neuroprotection in Experimental Stroke - Jea-Young Lee; Vanessa Castelli; Brooke Bonsack; Alexandreya B. Coats; Lisset Navarro-Torres; Julian Garcia-Sanchez; Chase Kingsbury; Hung Nguyen; Arthur A. Vandenbark; Roberto Meza-Romero; Halina Offner; Cesar V. Borlongan (Translational Stroke Research, 2020)

Sex differences in the therapeutic effects of anti-PDL2 neutralizing antibody on stroke - Hilary A. Seifert; Wenbin Zhu; Arthur A. Vandenbark; Nabil J. Alkayed; Halina Offner (Metabolic Brain Disease, 2019)

Increased CD74 binding and EAE treatment efficacy of a modified DRα1 molecular construct - Roberto Meza-Romero; Gil Benedek; Grant Gerstner; Gail Kent; Ha Nguyen; Halina Offner; Arthur A. Vandenbark (Metabolic Brain Disease, 2019)

Antibiotics protect against EAE by increasing regulatory and anti-inflammatory cells - Hilary A. Seifert; Gil Benedek; Ha Nguyen; Grant Gerstner; Ying Zhang; Gail Kent; Arthur A. Vandenbark; Jürgen Bernhagen; Halina Offner (Metabolic Brain Disease, 2018)

Uncovering the Rosetta Stone: Report from the First Annual Conference on Key Elements in Translating Stroke Therapeutics from Pre-Clinical to Clinical - Gregory J. Bix; Justin F. Fraser; William J. Mack; S. Thomas Carmichael; Miguel Perez-Pinzon; Halina Offner; Lauren Sansing; Francesca Bosetti; Cenk Ayata; Keith R. Pennypacker (Translational Stroke Research, 2018)

Estrogen protects both sexes against EAE by promoting common regulatory cell subtypes independent of endogenous estrogen - Hilary A. Seifert; Gil Benedek; Ha Nguyen; Gail Kent; Arthur A. Vandenbark; Halina Offner (Metabolic Brain Disease, 2017)

DRα1-MOG-35-55 treatment reduces lesion volumes and improves neurological deficits after traumatic brain injury - Liu Yang; Zhijia Liu; Honglei Ren; Lei Zhang; Siman Gao; Li Ren; Zhi Chai; Roberto Meza-Romero; Gil Benedek; Arthur A Vandenbark; Halina Offner; Minshu Li (Metabolic Brain Disease, 2017)

DRα1-MOG-35-55 Reduces Permanent Ischemic Brain Injury - Jianyi Wang; Qing Ye; Jing Xu; Gil Benedek; Haiyue Zhang; Yuanyuan Yang; Huan Liu; Roberto Meza-Romero; Arthur A. Vandenbark; Halina Offner; Yanqin Gao (Translational Stroke Research, 2017)

Loss of PPARα perpetuates sex differences in stroke reflected by peripheral immune mechanisms - Abby L. Dotson; Jianming Wang; Jian Liang; Ha Nguyen; Dustin Manning; Julie A. Saugstad; Halina Offner (Metabolic Brain Disease, 2016)

Sex differences and the role of PPAR alpha in experimental stroke - Abby L. Dotson; Jianming Wang; Yingxin Chen; Dustin Manning; Ha Nguyen; Julie A. Saugstad; Halina Offner (Metabolic Brain Disease, 2016)

Partial MHC Constructs Treat Thromboembolic Ischemic Stroke Characterized by Early Immune Expansion - Abby L. Dotson; Yingxin Chen; Wenbin Zhu; Nicole Libal; Nabil J. Alkayed; Halina Offner (Translational Stroke Research, 2016)

Role for microglia in sex differences after ischemic stroke: importance of M2 - Sheetal Bodhankar; Andrew Lapato; Yingxin Chen; Arthur A. Vandenbark; Julie A. Saugstad; Halina Offner (Metabolic Brain Disease, 2015)

Treatment with IL-10 producing B cells in combination with E2 ameliorates EAE severity and decreases CNS inflammation in B cell-deficient mice - Jun Zhang; Andrew Lapato; Sheetal Bodhankar; Arthur A. Vandenbark; Halina Offner (Metabolic Brain Disease, 2015)

Regulatory CD8+CD122+ T-cells predominate in CNS after treatment of experimental stroke in male mice with IL-10-secreting B-cells - Sheetal Bodhankar; Yingxin Chen; Andrew Lapato; Arthur A. Vandenbark; Stephanie J. Murphy; Julie A. Saugstad; Halina Offner (Metabolic Brain Disease, 2015)

Preclinical Evaluation of Recombinant T Cell Receptor Ligand RTL1000 as a Therapeutic Agent in Ischemic Stroke - Wenbin Zhu; Amanda Casper; Nicole L. Libal; Stephanie J. Murphy; Sheetal Bodhankar; Halina Offner; Nabil J. Alkayed (Translational Stroke Research, 2015)

Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis - Norah G. Verbout; Xiaolin Yu; Laura D. Healy; Kevin G. Phillips; Erik I. Tucker; András Gruber; Owen J. T. McCarty; Halina Offner (Metabolic Brain Disease, 2015)

Recombinant T Cell Receptor Ligand Treatment Improves Neurological Outcome in the Presence of Tissue Plasminogen Activator in Experimental Ischemic Stroke - Wenbin Zhu; Nicole L. Libal; Amanda Casper; Sheetal Bodhankar; Halina Offner; Nabil J. Alkayed (Translational Stroke Research, 2014)

Novel Humanized Recombinant T Cell Receptor Ligands Protect the Female Brain After Experimental Stroke - Jie Pan; Julie Palmateer; Timothy Schallert; Madison Hart; Arushi Pandya; Arthur A. Vandenbark; Halina Offner; Patricia D. Hurn (Translational Stroke Research, 2014)

Erratum to: A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke - Gil Benedek; Wenbin Zhu; Nicole Libal; Amanda Casper; Xiaolin Yu; Roberto Meza-Romero; Arthur A. Vandenbark; Nabil J. Alkayed; Halina Offner (Metabolic Brain Disease, 2014)

Treatment of experimental stroke with IL-10-producing B-cells reduces infarct size and peripheral and CNS inflammation in wild-type B-cell-sufficient mice - Sheetal Bodhankar; Yingxin Chen; Arthur A. Vandenbark; Stephanie J. Murphy; Halina Offner (Metabolic Brain Disease, 2014)

A novel HLA-DRα1-MOG-35-55 construct treats experimental stroke - Gil Benedek; Wenbin Zhu; Nicole Libal; Amanda Casper; Xiaolin Yu; Roberto Meza-Romero; Arthur A. Vandenbark; Nabil J. Alkayed; Halina Offner (Metabolic Brain Disease, 2014)

Phenotypic Changes in Immune Cell Subsets Reflect Increased Infarct Volume in Male vs. Female Mice - Anirban Banerjee; Jianming Wang; Sheetal Bodhankar; Arthur A. Vandenbark; Stephanie J. Murphy; Halina Offner (Translational Stroke Research, 2013)

IL-10-producing B-cells limit CNS inflammation and infarct volume in experimental stroke - Sheetal Bodhankar; Yingxin Chen; Arthur A. Vandenbark; Stephanie J. Murphy; Halina Offner (Metabolic Brain Disease, 2013)

Intrastriatal B-cell administration limits infarct size after stroke in B-cell deficient mice - Yingxin Chen; Sheetal Bodhankar; Stephanie J. Murphy; Arthur A. Vandenbark; Nabil J. Alkayed; Halina Offner (Metabolic Brain Disease, 2012)

A Novel Hypothesis: Regulatory B Lymphocytes Shape Outcome from Experimental Stroke - Halina Offner; Patricia D. Hurn (Translational Stroke Research, 2012)

Gilt required for RTL550-CYS-MOG to treat experimental autoimmune encephalomyelitis - Gregory G. Burrows; Roberto Meza-Romero; Jianya Huan; Sushmita Sinha; Jeffrey L. Mooney; Arthur A. Vandenbark; Halina Offner (Metabolic Brain Disease, 2012)

Contribution of GPR30 for 1,25 dihydroxyvitamin D3 protection in EAE - Sandhya Subramanian; Lisa M. Miller; Marjorie R. Grafe; Arthur A. Vandenbark; Halina Offner (Metabolic Brain Disease, 2012)

Myelin specific cells infiltrate MCAO lesions and exacerbate stroke severity - Xuefang Ren; Kozaburo Akiyoshi; Marjorie R. Grafe; Arthur A. Vandenbark; Patricia D. Hurn; Paco S. Herson; Halina Offner (Metabolic Brain Disease, 2012)

Recombinant T Cell Receptor Ligands Improve Outcome After Experimental Cerebral Ischemia - Kozaburo Akiyoshi; Suzan Dziennis; Julie Palmateer; Xuefang Ren; Arthur A. Vandenbark; Halina Offner; Paco S. Herson; Patricia D. Hurn (Translational Stroke Research, 2011)

Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice - Suzan Dziennis; Sarah Mader; Kozaburo Akiyoshi; Xuefang Ren; Patricia Ayala; Gregory G. Burrows; Arthur A. Vandenbark; Paco S. Herson; Patricia D. Hurn; Halina A. Offner (Metabolic Brain Disease, 2011)

Sustained expression of circulating human alpha-1 antitrypsin reduces inflammation, increases CD4+FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice - Sandhya Subramanian; Galit Shahaf; Eyal Ozeri; Lisa M. Miller; Arthur A. Vandenbark; Eli C. Lewis; Halina Offner (Metabolic Brain Disease, 2011)

CD4+FoxP3+ regulatory T-cells in cerebral ischemic stroke - Xuefang Ren; Kozaburo Akiyoshi; Arthur A. Vandenbark; Patricia D. Hurn; Halina Offner (Metabolic Brain Disease, 2011)

Recombinant TCR Ligand Reverses Clinical Signs and CNS Damage of EAE Induced by Recombinant Human MOG - Sushmita Sinha; Sandhya Subramanian; Ashley Emerson-Webber; Maren Lindner; Gregory G. Burrows; Marjorie Grafe; Christopher Linington; Arthur A. Vandenbark; Claude C. A. Bernard; Halina Offner (Journal of Neuroimmune Pharmacology, 2010)